SEQUENT - Sequent Scientific

Sequent Scientific

SEQUENT · Pharma > Pharmaceuticals & Drugs · Chairman: Kamal K Sharma · MD: Manish Gupta · Listing date: March 11, 2016 · Employees: 1770 · Bangalore · http://www.sequent.in

Stock Price vs Company Growth

1.3%

3.3%

7.9%

14.3%

21.1%

55.5%

12.2%

all

4.6%

🤔 How to analyze this graph?

Last Traded Price

₹ 121 1.3%

112

155

Company Overview

Sales

1,375 Cr

Growth: 0.9%

Profit after Tax

-139 Cr

Growth: -9.4%

Small Cap

3,015 Cr

P/S: 2.2x

Industry P/S: 2.6x

Fundamentals

Sales (Cr)	₹ 1,375
Growth	0.9%
EBITDA	1.9%
P/S	2.2x
Dividend	0.0%
P/E	-23.3x
Book Value	₹ 26.2
PEG Ratio	-27.1x
ROE	-20.9%
P/B	4.6x

Shareholding Pattern

Institutions

Infinity Holdings

5.91 %

Unit Trust Of India Investment Advisory Services Limited A/C Ascent India Fund Iii

3.35 %

Ashoka India Opportunities Fund

1.35 %

Sbi Healthcare Opportunities Fund

1.21 %

Mukul Mahavir Agrawal

1.05 %

Promoters

Ca Harbor Investments

53.02 %

Chayadeep Ventures Llp

0.27 %

Rajitha Gopalakrishnan

0.2 %

Sajitha Pillai

0.15 %

Vineetha Mohanakumar Pillai

0.12 %

Others

Increase Decrease No change

Company Profile Detailed

Sequent Scientific earlier known as P I Drugs & Pharmaceuticals is an integrated pharmaceutical company. Hon'ble High Court of Bombay approved the Scheme of Amalgamation of company with P I Drugs & Pharmaceuticals Ltd.

Belongs to (7 Indices) view more

Investors (89)

tushar.p...

dilip.sh...

harish.n...

Followers (7)

jose4

joy2

ratnesh2